Laboratory News and Research

RSS
Coagadex now approved by FDA for patients with hereditary Factor X deficiency

Coagadex now approved by FDA for patients with hereditary Factor X deficiency

LSTM CL3 lab refurbished by Medical Air Technology

LSTM CL3 lab refurbished by Medical Air Technology

Melatonin and the circadian rhythm: an interview with Professor Kennaway, University of Adelaide

Melatonin and the circadian rhythm: an interview with Professor Kennaway, University of Adelaide

Bioengineers develop continuously tunable method to find and quantify DNA, RNA biomarkers

Bioengineers develop continuously tunable method to find and quantify DNA, RNA biomarkers

Honeywell inks definitive agreement to acquire Sigma-Aldrich's laboratory research chemicals business

Honeywell inks definitive agreement to acquire Sigma-Aldrich's laboratory research chemicals business

First patients receive doses of antisense drug for Huntington's disease

First patients receive doses of antisense drug for Huntington's disease

Research finding points towards developing effective malaria vaccine

Research finding points towards developing effective malaria vaccine

NAM announces election of three new members from UC San Diego School of Medicine

NAM announces election of three new members from UC San Diego School of Medicine

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

Biophor receives FDA 510(k) clearance for distribution of seventh oral fluid screening assay

Biophor receives FDA 510(k) clearance for distribution of seventh oral fluid screening assay

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Breakthrough advancements on new molecular mechanism may lead to Parkinson's treatments

Breakthrough advancements on new molecular mechanism may lead to Parkinson's treatments

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

Baylor study identifies biomarker that could help determine treatment strategies for colorectal cancer patients

Baylor study identifies biomarker that could help determine treatment strategies for colorectal cancer patients

TGen researchers join international scientists in discovering how malaria protein could some day help stop cancer

TGen researchers join international scientists in discovering how malaria protein could some day help stop cancer

FDA grants accelerated approval to Praxbind (idarucizumab)

FDA grants accelerated approval to Praxbind (idarucizumab)

Brown University researchers describe new method to test HIV mutations

Brown University researchers describe new method to test HIV mutations

New breakthrough advances our understanding of how brain detects, prevents dehydration

New breakthrough advances our understanding of how brain detects, prevents dehydration

Researchers create high resolution images of telomerase that plays major role in cancer, aging

Researchers create high resolution images of telomerase that plays major role in cancer, aging

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.